Genentech (DNA) Joins The 52-Week Low Club

Print Email

Genentech (DNA) Big biopharma drops on poort clinical trial results for its drug Avastin. Down to $75.56 from 52-week high of $89.73.

Verasun Energy (VSE) Rise in supply of ethanol could hurt margins. Shares drop to $14.36 from 52-week high of $30.75.

Northwest Air (NWA) Just out of Chapter 11. Not a nice reception as oil prices hurt airline shares. Down to $23.85 just a few days from emerging. The high since then is $26.50.

Spatialight (HDTV) Bad news about largest customer and delisting keep dogging it. Down to $.07 from $3.10.

Transmeta (TMTA) Chip maker has unhealthy loss in latest quarter. Drops to $.28 from 52-week high of $1.75.

Mannkind (MNKD) Drug development firm had rought quarter. Down to $10.18 from 52-week high of $21.74.

Douglas A. McIntyre

RSS Facebook Twitter